However, caution is needed in interpreting this study. First, data were available only on adults aged 20-59 years at baseline, so that the average age at the end of follow-up was approximately 57 years, which is young for assessing cardiovascular mortality effects. Other than cigarette smoking, few, if any, chemical exposures are known to trigger a 3-fold increase in the risk of death from heart disease, especially in persons younger than 60 years, suggesting that other, as yet unknown, factors may be associated with these increased risks.
Second, while cardiovascular effects associated with pyrethroid exposure have been observed experimentally in rodents and other animals, 4 to date there is little epidemiological evidence to suggest such effects in humans. A single case-control study of coronary heart disease cited by the authors reports an odds ratio of 3.6 for the upper compared with the lower tertile of 3-PBA; in that study, the average age of participants with coronary heart disease was 62.5 years, or only about 5 years older than participants in the NHANES, while the biomarker levels were considerably greater than those in the NHANES population. 6 Further detailed studies based on validated exposure assessment methods, including both questionnaires and biomarkers, are needed to assess these toxicological parameters.
Pyrethroid pesticides are ubiquitous, and exposure is unavoidable; in New York City and elsewhere, aerial spraying for mosquito control to prevent West Nile virus and other vector-borne illnesses is largely based on pyrethroids. 7 This study challenges the assumption that such exposures are safe. The unusually large hazard ratios observed deserve immediate further exploration, which would contribute to more evidence-based options in weighing risks and benefits of essential insect control programs.
